Skip to main content
BMJ Open logoLink to BMJ Open
. 2017 Apr 7;7(4):e006733corr1. doi: 10.1136/bmjopen-2014-006733corr1

Correction

PMCID: PMC5541198  PMID: 28389497

Khan I, Morris S, Hackshaw A, et al. Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy. BMJ Open 2015;5:e006733. doi: 10.1136/bmjopen-2014-006733

In figure 1, the top square currently reads ‘370 Randomised’. This should read ‘670 Randomised’ as mentioned earlier in the text.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES